Vanda Pharmaceuticals (VNDA) Cash & Equivalents Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.61% |
| Dec 31, 2025 | 6.81% |
| Sep 30, 2025 | 4.21% |
| Jun 30, 2025 | -3.20% |
| Mar 31, 2025 | 11.47% |
| Dec 31, 2024 | 17.82% |
| Sep 30, 2024 | 20.71% |
| Jun 30, 2024 | 17.21% |
| Mar 31, 2024 | 29.49% |
| Dec 31, 2023 | 17.36% |
| Sep 30, 2023 | 24.69% |
| Jun 30, 2023 | 19.76% |
| Mar 31, 2023 | 17.93% |
| Dec 31, 2022 | 32.05% |
| Sep 30, 2022 | 16.94% |
| Jun 30, 2022 | 32.55% |
| Mar 31, 2022 | 27.18% |
| Dec 31, 2021 | -12.39% |
| Sep 30, 2021 | 9.05% |
| Jun 30, 2021 | 19.80% |
| Mar 31, 2021 | 13.24% |
| Dec 31, 2020 | 3.72% |
| Sep 30, 2020 | 4.02% |
| Jun 30, 2020 | 14.54% |
| Mar 31, 2020 | 14.63% |
| Dec 31, 2019 | -5.84% |
| Sep 30, 2019 | 20.70% |
| Jun 30, 2019 | 22.32% |
| Mar 31, 2019 | -4.49% |
| Dec 31, 2018 | -1.19% |
| Sep 30, 2018 | -15.63% |
| Jun 30, 2018 | -10.09% |
| Mar 31, 2018 | 7.15% |
| Dec 31, 2017 | -17.65% |
| Sep 30, 2017 | -26.39% |
| Jun 30, 2017 | -31.50% |
| Mar 31, 2017 | -28.56% |
| Dec 31, 2016 | 2.79% |
| Sep 30, 2016 | -11.49% |
| Jun 30, 2016 | -14.37% |
| Mar 31, 2016 | -5.90% |
| Dec 31, 2015 | 3.62% |
| Sep 30, 2015 | -14.51% |
| Jun 30, 2015 | -19.80% |
| Dec 31, 2014 | -21.58% |